National

Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla

The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccine doses in November this year.

Advertisement

Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla
info_icon

The Serum Institute of India (SII) has increased its capacity to produce 240 million AstraZeneca Covid-19 doses making it capable to export large volumes of the vaccine.

According to Reuters, the company’s CEO Adar Poonawalla said it will produce 220-240 million AstraZeneca vaccine doses.

He added the company may be able to export up to 30 million doses a month in November and December.

He said the company has revamped its infrastructure to produce the required Covid-19 doses.

Poonaawalla said SII would also make the single-dose Sputnik Light vaccine.

He also said the company would also produce 50 million to 100 million doses of the Novavax vaccine by the end of this year.

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement